Mäurer, M.; Schott, D.; Pizon, M.; Drozdz, S.; Wendt, T.; Wittig, A.; Pachmann, K.
Increased Circulating Epithelial Tumor Cells (CETC/CTC) over the Course of Adjuvant Radiotherapy Is a Predictor of Less Favorable Outcome in Patients with Early-Stage Breast Cancer. Curr. Oncol. 2023, 30, 261-273.
https://doi.org/10.3390/curroncol30010021
AMA Style
Mäurer M, Schott D, Pizon M, Drozdz S, Wendt T, Wittig A, Pachmann K.
Increased Circulating Epithelial Tumor Cells (CETC/CTC) over the Course of Adjuvant Radiotherapy Is a Predictor of Less Favorable Outcome in Patients with Early-Stage Breast Cancer. Current Oncology. 2023; 30(1):261-273.
https://doi.org/10.3390/curroncol30010021
Chicago/Turabian Style
Mäurer, Matthias, Dorothea Schott, Monika Pizon, Sonia Drozdz, Thomas Wendt, Andrea Wittig, and Katharina Pachmann.
2023. "Increased Circulating Epithelial Tumor Cells (CETC/CTC) over the Course of Adjuvant Radiotherapy Is a Predictor of Less Favorable Outcome in Patients with Early-Stage Breast Cancer" Current Oncology 30, no. 1: 261-273.
https://doi.org/10.3390/curroncol30010021
APA Style
Mäurer, M., Schott, D., Pizon, M., Drozdz, S., Wendt, T., Wittig, A., & Pachmann, K.
(2023). Increased Circulating Epithelial Tumor Cells (CETC/CTC) over the Course of Adjuvant Radiotherapy Is a Predictor of Less Favorable Outcome in Patients with Early-Stage Breast Cancer. Current Oncology, 30(1), 261-273.
https://doi.org/10.3390/curroncol30010021
